Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Application of Direct Viral Cytopathic Hypothesis to Design Drug Trials in the Battle Against Covid-19 Publisher Pubmed



Ashraf MA1 ; Sherafat A2 ; Pourdast A3, 4 ; Nazemi P4 ; Mohraz M3
Authors

Source: DARU# Journal of Pharmaceutical Sciences Published:2020


Abstract

COVID-19 has caused many deaths worldwide. Systemic complications alongside coagulopathy, and ARDS account for the majority of COVID-19 mortalities. The pathogenesis of the disease can be explained by two theories of direct viral cytopathy and systemic inflammatory cascade of events. ACE-2 is shown to be the cellular host receptor for SARS-CoV-2. It might be the key to explain the pathogenesis of systemic complications with a focus on the direct viral cytopathic hypothesis. Different medications tend to show up in many in vitro drug screens. However, more trials are needed to translate their application into in vivo efficacy. © 2020, Springer Nature Switzerland AG.
Related Docs
View other Related Docs
1. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
2. The Possible Double-Edged Sword Effects of Vitamin D on Covid-19: A Hypothesis, Cell Biology International (2021)
3. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Reza Afrisham (2)
Other Related Docs
4. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
5. Renal, Cardiac, Neurological, Cutaneous and Coagulopathic Long-Term Manifestations of Covid-19 After Recovery; a Review, Epidemiology and Infection (2022)
6. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
7. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
8. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
9. An Overview of the Recent Findings of Cell-Based Therapies for the Treatment and Management of Covid-19, International Immunopharmacology (2021)
10. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
11. Severe Acute Respiratory Syndrome and Thyroid: A Molecular Point of View, Clinical Nutrition ESPEN (2022)
12. Molecular Mechanisms and Therapeutic Effects of Different Vitamins and Minerals in Covid-19 Patients, Journal of Trace Elements in Medicine and Biology (2022)
13. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
14. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
15. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
16. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
17. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
18. The Prophylaxis and Treatment Potential of Supplements for Covid-19, European Journal of Pharmacology (2020)
19. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
20. Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-Term Symptoms of Covid-19 After Recovery: A Review, Mini-Reviews in Medicinal Chemistry (2023)